English
简体中文
Total: £ 56.28
Published Date: 2025-11-19 | Pages: 126 | Tables: 113 | Pharma & Healthcare
The global market for Anti-Venom was estimated to be worth US$ 1041 million in 2024 and is forecast to a readjusted size of US$ 1383 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
This report aims to provide a comprehensive presentation of the global market for Anti-Venom, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-Venom by region & country, by Type, and by Application.
The Anti-Venom market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Venom.
Market Segmentation
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Segment by Type
Polyvalent Anti-Venom
Monovalent Anti-Venom
Segment by Application
Non-profit Institutions
Hospitals and Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-Venom manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-Venom in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-Venom in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Anti-Venom Product Introduction
1.2 Global Anti-Venom Market Size Forecast
1.2.1 Global Anti-Venom Sales Value (2020-2031)
1.2.2 Global Anti-Venom Sales Volume (2020-2031)
1.2.3 Global Anti-Venom Sales Price (2020-2031)
1.3 Anti-Venom Market Trends & Drivers
1.3.1 Anti-Venom Industry Trends
1.3.2 Anti-Venom Market Drivers & Opportunity
1.3.3 Anti-Venom Market Challenges
1.3.4 Anti-Venom Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-Venom Players Revenue Ranking (2024)
2.2 Global Anti-Venom Revenue by Company (2020-2025)
2.3 Global Anti-Venom Players Sales Volume Ranking (2024)
2.4 Global Anti-Venom Sales Volume by Company Players (2020-2025)
2.5 Global Anti-Venom Average Price by Company (2020-2025)
2.6 Key Manufacturers Anti-Venom Manufacturing Base and Headquarters
2.7 Key Manufacturers Anti-Venom Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-Venom
2.9 Anti-Venom Market Competitive Analysis
2.9.1 Anti-Venom Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti-Venom Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Venom as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Polyvalent Anti-Venom
3.1.2 Monovalent Anti-Venom
3.2 Global Anti-Venom Sales Value by Type
3.2.1 Global Anti-Venom Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Anti-Venom Sales Value, by Type (2020-2031)
3.2.3 Global Anti-Venom Sales Value, by Type (%) (2020-2031)
3.3 Global Anti-Venom Sales Volume by Type
3.3.1 Global Anti-Venom Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Anti-Venom Sales Volume, by Type (2020-2031)
3.3.3 Global Anti-Venom Sales Volume, by Type (%) (2020-2031)
3.4 Global Anti-Venom Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Non-profit Institutions
4.1.2 Hospitals and Clinic
4.2 Global Anti-Venom Sales Value by Application
4.2.1 Global Anti-Venom Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Anti-Venom Sales Value, by Application (2020-2031)
4.2.3 Global Anti-Venom Sales Value, by Application (%) (2020-2031)
4.3 Global Anti-Venom Sales Volume by Application
4.3.1 Global Anti-Venom Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Anti-Venom Sales Volume, by Application (2020-2031)
4.3.3 Global Anti-Venom Sales Volume, by Application (%) (2020-2031)
4.4 Global Anti-Venom Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Anti-Venom Sales Value by Region
5.1.1 Global Anti-Venom Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Anti-Venom Sales Value by Region (2020-2025)
5.1.3 Global Anti-Venom Sales Value by Region (2026-2031)
5.1.4 Global Anti-Venom Sales Value by Region (%), (2020-2031)
5.2 Global Anti-Venom Sales Volume by Region
5.2.1 Global Anti-Venom Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Anti-Venom Sales Volume by Region (2020-2025)
5.2.3 Global Anti-Venom Sales Volume by Region (2026-2031)
5.2.4 Global Anti-Venom Sales Volume by Region (%), (2020-2031)
5.3 Global Anti-Venom Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Anti-Venom Sales Value, 2020-2031
5.4.2 North America Anti-Venom Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Anti-Venom Sales Value, 2020-2031
5.5.2 Europe Anti-Venom Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Anti-Venom Sales Value, 2020-2031
5.6.2 Asia Pacific Anti-Venom Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Anti-Venom Sales Value, 2020-2031
5.7.2 South America Anti-Venom Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti-Venom Sales Value, 2020-2031
5.8.2 Middle East & Africa Anti-Venom Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-Venom Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Anti-Venom Sales Value
6.2.1 Key Countries/Regions Anti-Venom Sales Value, 2020-2031
6.2.2 Key Countries/Regions Anti-Venom Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Anti-Venom Sales Value, 2020-2031
6.3.2 United States Anti-Venom Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Anti-Venom Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Anti-Venom Sales Value, 2020-2031
6.4.2 Europe Anti-Venom Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Anti-Venom Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Anti-Venom Sales Value, 2020-2031
6.5.2 China Anti-Venom Sales Value by Type (%), 2024 VS 2031
6.5.3 China Anti-Venom Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Anti-Venom Sales Value, 2020-2031
6.6.2 Japan Anti-Venom Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Anti-Venom Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Anti-Venom Sales Value, 2020-2031
6.7.2 South Korea Anti-Venom Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Anti-Venom Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-Venom Sales Value, 2020-2031
6.8.2 Southeast Asia Anti-Venom Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Anti-Venom Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Anti-Venom Sales Value, 2020-2031
6.9.2 India Anti-Venom Sales Value by Type (%), 2024 VS 2031
6.9.3 India Anti-Venom Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 CSL
7.1.1 CSL Company Information
7.1.2 CSL Introduction and Business Overview
7.1.3 CSL Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 CSL Anti-Venom Product Offerings
7.1.5 CSL Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Merck Anti-Venom Product Offerings
7.2.5 Merck Recent Development
7.3 BTG
7.3.1 BTG Company Information
7.3.2 BTG Introduction and Business Overview
7.3.3 BTG Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 BTG Anti-Venom Product Offerings
7.3.5 BTG Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Pfizer Anti-Venom Product Offerings
7.4.5 Pfizer Recent Development
7.5 Haffkine Bio-Pharmaceutical
7.5.1 Haffkine Bio-Pharmaceutical Company Information
7.5.2 Haffkine Bio-Pharmaceutical Introduction and Business Overview
7.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Product Offerings
7.5.5 Haffkine Bio-Pharmaceutical Recent Development
7.6 Rare Disease Therapeutics
7.6.1 Rare Disease Therapeutics Company Information
7.6.2 Rare Disease Therapeutics Introduction and Business Overview
7.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Rare Disease Therapeutics Anti-Venom Product Offerings
7.6.5 Rare Disease Therapeutics Recent Development
7.7 Flynn Pharma
7.7.1 Flynn Pharma Company Information
7.7.2 Flynn Pharma Introduction and Business Overview
7.7.3 Flynn Pharma Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Flynn Pharma Anti-Venom Product Offerings
7.7.5 Flynn Pharma Recent Development
7.8 Vins Bioproducts
7.8.1 Vins Bioproducts Company Information
7.8.2 Vins Bioproducts Introduction and Business Overview
7.8.3 Vins Bioproducts Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Vins Bioproducts Anti-Venom Product Offerings
7.8.5 Vins Bioproducts Recent Development
7.9 Bharat Serums and Vaccines
7.9.1 Bharat Serums and Vaccines Company Information
7.9.2 Bharat Serums and Vaccines Introduction and Business Overview
7.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Bharat Serums and Vaccines Anti-Venom Product Offerings
7.9.5 Bharat Serums and Vaccines Recent Development
7.10 Serum Biotech
7.10.1 Serum Biotech Company Information
7.10.2 Serum Biotech Introduction and Business Overview
7.10.3 Serum Biotech Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Serum Biotech Anti-Venom Product Offerings
7.10.5 Serum Biotech Recent Development
7.11 MicroPharm
7.11.1 MicroPharm Company Information
7.11.2 MicroPharm Introduction and Business Overview
7.11.3 MicroPharm Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 MicroPharm Anti-Venom Product Offerings
7.11.5 MicroPharm Recent Development
8 Industry Chain Analysis
8.1 Anti-Venom Industrial Chain
8.2 Anti-Venom Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-Venom Sales Model
8.5.2 Sales Channel
8.5.3 Anti-Venom Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Anti-Venom Market Trends
Table 2. Anti-Venom Market Drivers & Opportunity
Table 3. Anti-Venom Market Challenges
Table 4. Anti-Venom Market Restraints
Table 5. Global Anti-Venom Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Anti-Venom Revenue Market Share by Company (2020-2025)
Table 7. Global Anti-Venom Sales Volume by Company (2020-2025) & (K Vials)
Table 8. Global Anti-Venom Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Anti-Venom Price by Company (2020-2025) & (USD/Vial)
Table 10. Key Manufacturers Anti-Venom Manufacturing Base and Headquarters
Table 11. Key Manufacturers Anti-Venom Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Anti-Venom
Table 13. Global Anti-Venom Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Venom as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Venom Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Anti-Venom Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Anti-Venom Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Anti-Venom Sales Market Share in Value by Type (2020-2025)
Table 20. Global Anti-Venom Sales Market Share in Value by Type (2026-2031)
Table 21. Global Anti-Venom Sales Volume by Type: 2020 VS 2024 VS 2031 (K Vials)
Table 22. Global Anti-Venom Sales Volume by Type (2020-2025) & (K Vials)
Table 23. Global Anti-Venom Sales Volume by Type (2026-2031) & (K Vials)
Table 24. Global Anti-Venom Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Anti-Venom Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Anti-Venom Price by Type (2020-2025) & (USD/Vial)
Table 27. Global Anti-Venom Price by Type (2026-2031) & (USD/Vial)
Table 28. Global Anti-Venom Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Anti-Venom Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Anti-Venom Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Anti-Venom Sales Market Share in Value by Application (2020-2025)
Table 32. Global Anti-Venom Sales Market Share in Value by Application (2026-2031)
Table 33. Global Anti-Venom Sales Volume by Application: 2020 VS 2024 VS 2031 (K Vials)
Table 34. Global Anti-Venom Sales Volume by Application (2020-2025) & (K Vials)
Table 35. Global Anti-Venom Sales Volume by Application (2026-2031) & (K Vials)
Table 36. Global Anti-Venom Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Anti-Venom Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Anti-Venom Price by Application (2020-2025) & (USD/Vial)
Table 39. Global Anti-Venom Price by Application (2026-2031) & (USD/Vial)
Table 40. Global Anti-Venom Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Anti-Venom Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Anti-Venom Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Anti-Venom Sales Value by Region (2020-2025) & (%)
Table 44. Global Anti-Venom Sales Value by Region (2026-2031) & (%)
Table 45. Global Anti-Venom Sales Volume by Region (K Vials): 2020 VS 2024 VS 2031
Table 46. Global Anti-Venom Sales Volume by Region (2020-2025) & (K Vials)
Table 47. Global Anti-Venom Sales Volume by Region (2026-2031) & (K Vials)
Table 48. Global Anti-Venom Sales Volume by Region (2020-2025) & (%)
Table 49. Global Anti-Venom Sales Volume by Region (2026-2031) & (%)
Table 50. Global Anti-Venom Average Price by Region (2020-2025) & (USD/Vial)
Table 51. Global Anti-Venom Average Price by Region (2026-2031) & (USD/Vial)
Table 52. Key Countries/Regions Anti-Venom Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Anti-Venom Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Anti-Venom Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Anti-Venom Sales Volume, (2020-2025) & (K Vials)
Table 56. Key Countries/Regions Anti-Venom Sales Volume, (2026-2031) & (K Vials)
Table 57. CSL Company Information
Table 58. CSL Introduction and Business Overview
Table 59. CSL Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 60. CSL Anti-Venom Product Offerings
Table 61. CSL Recent Development
Table 62. Merck Company Information
Table 63. Merck Introduction and Business Overview
Table 64. Merck Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 65. Merck Anti-Venom Product Offerings
Table 66. Merck Recent Development
Table 67. BTG Company Information
Table 68. BTG Introduction and Business Overview
Table 69. BTG Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 70. BTG Anti-Venom Product Offerings
Table 71. BTG Recent Development
Table 72. Pfizer Company Information
Table 73. Pfizer Introduction and Business Overview
Table 74. Pfizer Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 75. Pfizer Anti-Venom Product Offerings
Table 76. Pfizer Recent Development
Table 77. Haffkine Bio-Pharmaceutical Company Information
Table 78. Haffkine Bio-Pharmaceutical Introduction and Business Overview
Table 79. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 80. Haffkine Bio-Pharmaceutical Anti-Venom Product Offerings
Table 81. Haffkine Bio-Pharmaceutical Recent Development
Table 82. Rare Disease Therapeutics Company Information
Table 83. Rare Disease Therapeutics Introduction and Business Overview
Table 84. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 85. Rare Disease Therapeutics Anti-Venom Product Offerings
Table 86. Rare Disease Therapeutics Recent Development
Table 87. Flynn Pharma Company Information
Table 88. Flynn Pharma Introduction and Business Overview
Table 89. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 90. Flynn Pharma Anti-Venom Product Offerings
Table 91. Flynn Pharma Recent Development
Table 92. Vins Bioproducts Company Information
Table 93. Vins Bioproducts Introduction and Business Overview
Table 94. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 95. Vins Bioproducts Anti-Venom Product Offerings
Table 96. Vins Bioproducts Recent Development
Table 97. Bharat Serums and Vaccines Company Information
Table 98. Bharat Serums and Vaccines Introduction and Business Overview
Table 99. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 100. Bharat Serums and Vaccines Anti-Venom Product Offerings
Table 101. Bharat Serums and Vaccines Recent Development
Table 102. Serum Biotech Company Information
Table 103. Serum Biotech Introduction and Business Overview
Table 104. Serum Biotech Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 105. Serum Biotech Anti-Venom Product Offerings
Table 106. Serum Biotech Recent Development
Table 107. MicroPharm Company Information
Table 108. MicroPharm Introduction and Business Overview
Table 109. MicroPharm Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 110. MicroPharm Anti-Venom Product Offerings
Table 111. MicroPharm Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Anti-Venom Downstream Customers
Table 115. Anti-Venom Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Venom Product Picture
Figure 2. Global Anti-Venom Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Anti-Venom Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Anti-Venom Sales Volume (2020-2031) & (K Vials)
Figure 5. Global Anti-Venom Sales Price (2020-2031) & (USD/Vial)
Figure 6. Anti-Venom Report Years Considered
Figure 7. Global Anti-Venom Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Anti-Venom Players Sales Volume Ranking (2024) & (K Vials)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Venom Revenue in 2024
Figure 10. Anti-Venom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Polyvalent Anti-Venom Picture
Figure 12. Monovalent Anti-Venom Picture
Figure 13. Global Anti-Venom Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Anti-Venom Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Anti-Venom Sales Volume by Type (2020 VS 2024 VS 2031) & (K Vials)
Figure 16. Global Anti-Venom Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Anti-Venom Price by Type (2020-2031) & (USD/Vial)
Figure 18. Product Picture of Non-profit Institutions
Figure 19. Product Picture of Hospitals and Clinic
Figure 20. Global Anti-Venom Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Anti-Venom Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Anti-Venom Sales Volume by Application (2020 VS 2024 VS 2031) & (K Vials)
Figure 23. Global Anti-Venom Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Anti-Venom Price by Application (2020-2031) & (USD/Vial)
Figure 25. North America Anti-Venom Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Anti-Venom Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Anti-Venom Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Anti-Venom Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Anti-Venom Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Anti-Venom Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Anti-Venom Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Anti-Venom Sales Volume (%), (2020-2031)
Figure 37. United States Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Anti-Venom Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Anti-Venom Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Anti-Venom Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Anti-Venom Sales Value by Application (%), 2024 VS 2031
Figure 43. China Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Anti-Venom Sales Value by Type (%), 2024 VS 2031
Figure 45. China Anti-Venom Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Anti-Venom Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Anti-Venom Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Anti-Venom Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Anti-Venom Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Anti-Venom Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Anti-Venom Sales Value by Application (%), 2024 VS 2031
Figure 55. India Anti-Venom Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Anti-Venom Sales Value by Type (%), 2024 VS 2031
Figure 57. India Anti-Venom Sales Value by Application (%), 2024 VS 2031
Figure 58. Anti-Venom Industrial Chain
Figure 59. Anti-Venom Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
